Where is Misonix located?

Misonix is headquartered in Farmingdale, United States.

Who is the current CEO of Misonix?

Stavros Vizirgianakis of Misonix. They are also an angel investors in 1 startup.

How many employees does Misonix have?

As of Aug 31, 2026, the latest employee count at Misonix is 52.

How much is Misonix worth?

The last known valuation of Misonix was $***** as of Jul 29, 2021.

What is the annual revenue of Misonix?

Annual revenue of Misonix is between $50M and $100M as on Jun 30, 2021

Where does Misonix rank among its competitors?

Misonix ranks 9th amongst 76 active competitors, of which 19 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Alesi Surgical, which secured $9.46M in Apr, 2026.

Who are the top competitors of Misonix?

Misonix's top competitors include Monteris, Aqua Medical and STARMed. Among them, Alesi Surgical secured the most recent funding round in April, 2026.

Misonix - 2026 Company Profile, Team, Funding, Competitors & Financials

Q: Is Misonix an acquired company?

Misonix got acquired by Bioventus on Jul 29, 2021.

Misonix is an acquired company based in Farmingdale (United States), founded in 1959. It operates as an Ultrasonic surgical devices for neurosurgical, spinal, advanced wound care and general surgery. , with last known valuation of $*****. The company has 76 active competitors, including 19 funded and 9 that have exited. Its top competitors include companies like Monteris, Aqua Medical and STARMed.

Company Details

Misonix specializes in the development and commercialization of ultrasonic surgical devices for neurosurgical, spinal, advanced wound care and general surgery. Their product offering includes Misonix BoneScalpel - a novel surgical device that slices crystalline bone while leaving elastic soft tissues largely unaffected; Misonix SonicOne - an ultrasonic surgical debridement system; and SonaStar - a ultrasonic aspiration system.

Key Metrics

Founded Year

1959

Location

Farmingdale, United States

Stage

Acquired

Last Known Valuation

$***** as on Jul 29, 2021

Investors

1315 Capital & 1 more

Ranked

9^th among 76 active competitors

Annual Revenue

$50M - $100M as on Jun 30, 2021

Employee Count

52 as on Aug 31, 2026

Investment & Acquisitions

Solsys Medical & 1 more

Similar Companies

Monteris & 90 more

Exit Details

Acquired by Bioventus (Jul 29, 2021)

View Misonix's full profile

Misonix is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MISONIX INC CIN: 880432 , United States, Active	May 21, 2019	$50M - $100M (As on Jun 30, 2021)	-	-

Misonix got acquired by Bioventus on Jul 29, 2021 at an acquisition amount of $*****.

Click here to take a look at Misonix's acquisition in detail

Misonix is a funded company. Misonix has 2 institutional investors.

View details of Misonix's funding rounds and investors

Misonix's employee count trend

Misonix has 52 employees as of Aug 26. Here is Misonix's employee count trend over the years:

Uncover Misonix's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Misonix include Monteris, Aqua Medical and STARMed. Here is the list of Top 10 competitors of Misonix, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Monteris 1999, Plymouth (United States), Series E	Minimally invasive robotic laser thermotherapy	$202M	BDC, InnovaHealth Partners & 16 others	59/100
2nd	Aqua Medical 2016, Santa Ana (United States), Series A	Developer of endoscopic ablation therapy for gastrointestinal diseases	$22.2M	ShangBay Capital, Ithaka Partners & 2 others	45/100
3rd	STARMed 2011, Goyang (South Korea), Unfunded	Developer of ablation systems	-	-	45/100
4th	SonaCare Medical 2004, Charlotte (United States), Series B	Minimally-invasive prostate treatment using HIFU technology for precision prostate care	$29M	Hercules Capital, MMV Financial & 2 others	43/100
5th	Venclose 2014, San Jose (United States), Acquired	Radiofrequency ablation system for treating venous reflux disease	$27.1M	Ally Bridge Group	42/100
6th	Domain Surgical 2009, Salt Lake City (United States), Acquired	Surgical technology innovator specializing in lasers, robotics, and image-guided applications	$42.4M	Orbimed, ventureCapital.org & 2 others	42/100
7th	Alesi Surgical 2009, Cardiff (United Kingdom), Series C	Developer of surgical smoke elimination systems for open and laparoscopic procedures	$37.2M	Earlybird, IW Capital & 9 others	42/100
8th	Baucor 2011, Irvine (United States), Unfunded	Industrial blades, machine knives, and CNC tools manufacturer	-	-	41/100
9th	Misonix 1959, Farmingdale (United States), Acquired	Ultrasonic surgical devices for neurosurgical, spinal, advanced wound care and general surgery	-	1315 Capital, SV Health Investors	41/100
10th	Thermedical 1995, Waltham (United States), Series A	Developer of thermal ablation therapy for ventricular tachycardia	$29.7M	National Cancer Institute, NIH & 4 others	40/100